drugset
drugset / Trial / NCT00913822

To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets

NCT00913822 ↗

Phase 1 Completed 36 enrolled Sandoz
RandomizedCrossoverOpen-labelTreatment

Summary

To demonstrate the relative bioavailability of Desipramine Hydrochloride tablets.

Timeline

Start
1987-12
Primary completion
1987-12
Completion
1987-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Desipramine Small molecule 100 mg —

Indications

depressive disorder